We are live on
!
Find out more
AWCI
Alpine Woods Capital Investors Portfolio holdings
AUM
$460M
1-Year Est. Return
30.5%
This Fund
S&P 500
This Quarter
Est. Return
-1.19%
1 Year Est. Return
+30.5%
3 Year Est. Return
+104.98%
5 Year Est. Return
+116.86%
10 Year Est. Return
+408.45%
AUM
$1.88B
AUM Growth
+$1.88B
(+48,631%)
Cap. Flow
+$93.7M
Cap. Flow
% of AUM
4.98%
Top 10 Holdings %
Top 10 Hldgs %
17.45%
Holding
496
New
47
Increased
98
Reduced
145
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Teva Pharmaceuticals
TEVA
|
+$14.1M |
| 2 |
Carter's
CRI
|
+$13.9M |
| 3 |
FedEx
FDX
|
+$13.8M |
| 4 |
Chevron
CVX
|
+$10.2M |
| 5 |
RTN
Raytheon Company
RTN
|
+$8.87M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$13.5M |
| 2 |
Meritage Homes
MTH
|
+$8.43M |
| 3 |
American Water Works
AWK
|
+$8.07M |
| 4 |
American Homes 4 Rent
AMH
|
+$7.83M |
| 5 |
Comcast
CMCSA
|
+$7.48M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 16.9% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 11.78% |
| 4 | Industrials | 11.36% |
| 5 | Technology | 10.71% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Teva Pharmaceuticals
TEVA
$42.8B
| $18.7M | 1% |
348,627
+265,402
| +319% | +$14.1M |
|
27
Cisco
CSCO
$489B
| $18.1M | 0.97% |
721,000
-13,500
| -2% | -$340K |
|
28
Citigroup
C
$231B
| $18.1M | 0.96% |
349,596
-24,000
| -6% | -$1.21M |
|
29
Walt Disney
DIS
$178B
| $17.9M | 0.95% |
201,400
| – | – |
|
|
30
Comcast
CMCSA
$90.4B
| $17.9M | 0.95% |
664,722
-273,100
| -29% | -$7.48M |
|
31
Eversource Energy
ES
$26.9B
| $17.4M | 0.93% |
392,900
+165,200
| +73% | +$7.43M |
|
32
HCA Healthcare
HCA
$89.8B
| $17.3M | 0.92% |
245,000
-64,000
| -21% | -$4.23M |
|
|
EMC
33
DELISTED
EMC CORPORATION
EMC
| $17.3M | 0.92% |
590,400
| – | – |
|
34
CMS Energy
CMS
$22B
| $17.1M | 0.91% |
575,000
+2,000
| +0.3% | +$59.7K |
|
35
TE Connectivity
TEL
$62B
| $16.3M | 0.87% |
295,463
+31,700
| +12% | +$1.97M |
|
36
Johnson & Johnson
JNJ
$629B
| $16.2M | 0.86% |
152,279
-13,100
| -8% | -$1.36M |
|
37
Boston Properties
BXP
$10.8B
| $15.9M | 0.85% |
137,761
+10,000
| +8% | +$1.2M |
|
38
Edgewell Personal Care
EPC
$1.32B
| $15.9M | 0.85% |
174,426
| – | – |
|
39
Thermo Fisher Scientific
TMO
$223B
| $15.9M | 0.85% |
130,650
| – | – |
|
|
RYL
40
DELISTED
RYLAND GROUP INC
RYL
| $15.8M | 0.84% |
476,000
+75,100
| +19% | +$2.73M |
|
41
PNC Financial Services
PNC
$102B
| $15.5M | 0.82% |
180,900
| – | – |
|
42
Colgate-Palmolive
CL
$73.6B
| $15.3M | 0.81% |
234,800
-1,900
| -0.8% | -$125K |
|
43
AB InBev
BUD
$156B
| $15.1M | 0.8% |
136,450
| – | – |
|
44
Union Pacific
UNP
$175B
| $15.1M | 0.8% |
139,460
+4,900
| +4% | +$507K |
|
45
Mondelez International
MDLZ
$79.3B
| $14.5M | 0.77% |
424,500
-10,000
| -2% | -$364K |
|
46
D.R. Horton
DHI
$40.8B
| $14M | 0.74% |
681,426
| – | – |
|
|
47
Carter's
CRI
$1.43B
| $14M | 0.74% |
+180,200
| New | +$13.9M |
|
48
Ryder
R
$10.1B
| $13.3M | 0.71% |
147,500
+41,500
| +39% | +$3.72M |
|
|
OPLN
49
Openlane
OPLN
$4.34B
| $13.1M | 0.7% |
1,210,646
-27
| -0% | -$309 |
|
50
Digital Realty Trust
DLR
$72.9B
| $12.6M | 0.67% |
202,600
-6,200
| -3% | -$394K |
|
Similar funds
MCB
FCMV
PC
PIN
AA
AC
UAM
PC
Alpine Woods Capital Investors's Q3 2014 Portfolio in Review
As of Q3 2014, Alpine Woods Capital Investors held 496 positions worth $1.88B, up 48,631% from $3.86M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Alpine Woods Capital Investors deployed $93.7M of net new capital in Q3 2014, opening 47 new positions and adding to 98 existing holdings. Its largest new stake was Carter's: 180,200 shares worth $14M.
By sector, the portfolio is most concentrated in Real Estate at 17% of assets, up from 8.5% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $13.5M trimmed.
- Alpine Woods Capital Investors's largest Q3 2014 buy was Carter's: 180,200 shares worth $14M.
- Alpine Woods Capital Investors added most to Teva Pharmaceuticals in Q3 2014, an estimated $14.1M increase.
- Alpine Woods Capital Investors's biggest Q3 2014 reduction was Pfizer, cutting an estimated $13.5M.
- Alpine Woods Capital Investors fully exited Pier 1 Imports, Inc. in Q3 2014, selling an estimated $11.3K.
- Alpine Woods Capital Investors's ten largest holdings make up 17% of its $1.88B portfolio in Q3 2014.
- Alpine Woods Capital Investors opened 47 new positions and closed 38 in Q3 2014.
- Alpine Woods Capital Investors's portfolio value rose 48,631% quarter-over-quarter to $1.88B.
Based on Alpine Woods Capital Investors's 13F filing for Q3 2014, filed 12 Nov 2014.